Carafate Oral Suspension 1G Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Carafate: Oral suspension (1g)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Carafate 1g/10ml Susp
Drug Image file default-drug-image.png
Carafate 1g/10ml Susp
Drug Image file default-drug-image.png
Carafate 1g/10ml Susp
Drug Image file default-drug-image.png
Carafate 1g/10ml Susp

What is this Medicine?

SUCRALFATE (SOO kral fate) helps to treat ulcers of the intestine.

CVS Pharmacy Patient Statistics for Carafate: Oral suspension(1g)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Carafate 1g/10ml Suspension

NDC: 589140170
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Duodenal Ulcer

Sometimes used for but not FDA approved for the following conditions:
Esophagitis, NSAID-induced Ulcer Prophylaxis, Gastric Ulcer, Stress Gastritis Prophylaxis, Gastroesophageal Reflux Disease (GERD), Stomatitis, Aphthous Ulcer

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Carafate 1g/10ml Suspension

Reported Side Effects for Carafate 1g/10ml Suspension

Upset Stomach Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
<0.5%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Balance Problems Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<0.5%*
Severity: MILD
Onset: RAPID
Headache Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Carafate 1g/10ml Suspension

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Minor Lifestyle Interaction
Enteral Feedings and Carafate 1g/10ml Suspension(Sucralfate)
Enteral Feedings and Sucralfate(Sucralfate)
Sucralfate tablets and suspensions should be taken on an empty stomach. Do not take sucralfate tablets or suspensions at the same time as Enteral feedings (examples: Boost, Ensure, Jevity, Sustical and others). Enteral feedings are not compatible with Sucralfate. If administered together, a gooey substance may form which may cause stomach or bowel blockage. Such interactions are very rare. However, to avoid this interaction, take Sucralfate on an empty stomach, at least 1 hour before taking any nutritional supplement beverages by mouth or down a tube.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Carafate

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.